UNITE
Register
Register
Register

ProductUpdated on 17 July 2025

Plug-and-Play Molecular Diagnostics: Oncology & Infection Panels for Clinical Labs

CBDO at HQ Science Ltd

London, United Kingdom

About

HQ Science provides a ready-to-use molecular diagnostics platform for oncology and infectious disease testing, designed for effortless integration into clinical workflows.

Our system, Tachyon, is a compact, AI-powered unit that connects directly to Oxford Nanopore sequencers, delivering accurate genomic results within hours. It eliminates the need for costly lab infrastructure, trained bioinformaticians, or complex analysis pipelines.

Key features for clinical partners:

  • Plug-and-play deployment within a day

  • Oncology panels (e.g. recurrence risk) and infectious disease panels

  • Fully automated analysis with clinician-friendly reporting

  • Ongoing CE-IVDR and ISO 13485 certification

  • No hardware purchase required — provided under subscription with sufficient test volume

Current partners include:

Oscar Lambret Cancer Center, UK Health Security Agency, Oslo University Hospital, and Columbia University.

We’re onboarding new clinical sites across Europe. If you’re a diagnostic lab or oncology center looking to expand your molecular testing capabilities — we’d love to talk.

Looking for

  • Service
  • Product
  • Looking for project partners

Organisation

HQ Science Ltd

Startup/scaleup

Didcot, United Kingdom

Similar opportunities